Delivery Order SPE2DX22D0020-SPE2D826F13PP
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $495,295.50 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $74,615.40 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $30,977.72 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract has a completion date of January 8, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $25,308.36 by the Defense Logistics Agency's Medical Supply Chain on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price, non-set-aside contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The work will be performed at the...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $134,528.10 by the Defense Logistics Agency Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded without any set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at approximately $928K by the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, the company's corporate headquarters location. The delivery order represents a task order under a larger Indefinite Delivery Contract vehicle with the DLA...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $1,268.90 by the Defense Logistics Agency's Medical Supply Chain on January 14, 2026, with an ultimate completion date of January 15, 2026. The contract, which was competitively awarded with no set-aside designation, is being performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen's larger...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $124,469.46 by the Defense Logistics Agency Medical Supply Chain on January 13, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 14, 2026, represents a task order under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will be...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,074.78 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, which utilizes no set-aside designation, represents a task order under a larger Indefinite Delivery Contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D826F13PPDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $359,118.63 by the Defense Logistics Agency's Medical Supply Chain on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, Amerisourcebergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's contract portfolio with DLA includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through its parent company Cencora, Inc., the contractor also maintains significant contract relationships with the Department of Veterans Affairs and other federal healthcare systems, demonstrating substantial capacity to fulfill essential pharmaceutical and medical supply requirements for military treatment facilities and government medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $359.1k | 1/12/26 |